Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Wednesday
Oct 01st
Home
Innovative Medicine Demand
Innovative Arthritis Medicine

osteoarthritis_rheumatoid_arthritis_by_ilovepiano.jpg

Demand: Innovative Arthritis Medicine

Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis. 

Company is looking to joint-venture, collaborative development or in-licensing of  non-prescrition products, on exclusive basis. 

For more details please contact Farmavita.Net. 

Innovative Medicines Offer
Technology Platform for Controlled and Site Specific Release of Active Pharmaceutical Ingredients

marigold_by_schroppyo.jpgFarmavita.Net member has developed technology which enables development of oral dosage forms with  controlled and site specific release of active pharmaceutical ingredients. Patent pending application.

Company is looking for following types of cooperation:
- Out-licensing
- Joint-venture and private equity partners
- Collaborative product development
- Consulting or contract research contracts

 
Generic Medicines - Offer
Pregabalin We offer for outlicensing European e-CTD format of Pregabalin caps (whole strength range). Dossier is ready and has been approved/registered in several EU countries. Preferred model is of business cooperation is License Fee + Supply with finished product.
 
OTC / Nutraceutical Demand
DL-Aspirin + Glycine

We would like to express our interest in acquiring CTD Europeen format for DL-Aspirin+Glycine (90%/10%) oral soluble form with supply of the sam. 

Please post your offer at below comment form. 

API/Technology Demand
Seeking: Fermentation technology of Pristinamycin

Inquiry:

An Asia based international company is looking for technologies in the following field:

Type of Tech Request: Licensing

Desired outcome:

Pristinamycin (CAS No:270076-60-3) is an antibiotic used primarily in the treatment of staphylococcal infections, and to a lesser extent streptococcal infections. We’re looking for a technology of Pristinamycin based on fermentation. Both of the strain and the process are included.

The technology should have over 5000u/ml fermentation titre and other competitive parameters, and not infringe on other patents and intellectual property right. It is better that it can be directly used for APIs industrial production.
 
Open Innovation
Open Source BioPharma Systems

Open source systems lure drug developers

apple2.jpgThe gradual spread of software automation in drug development may be getting a boost from open source systems. Most e-clinical systems today--from data capture and storage to trial management and operations--are proprietary, despite the excellent work that solutions providers have done to make their products compatible with existing standards-based and de facto standard industry systems.

Life Science Article
Analgesic Activity of Murdannia nudiflora (L) Brenan

murdannia_nudiflora

Phytochemical Standardization and Analgesic Activity of Murdannia nudiflora (L) Brenan

Our present communication deals with physicochemical parameters, preliminary phytochemical studies and pharmacological impact of Murdannia nudiflora (L) Brenan as analgesic plant which is used in folklore uses of Assam. No reports are available on standardization parameters hence, the present attempt was undertaken to investigate the standardization parameters to establish its authenticity. The study revealed the presence of wide range of phytoconstituents. The determination of these characters will aid future investigators in their Pharmacological analysis of this species. 

The whole 8 pages article is available for download at Downloads section of Farmavita.Net. 
 
Events
2015 Canadian Pharma Market Research Conference

Canadian Pharma Market Research Conference

 28-29, April, 2015, Toronto, Canada

2015-pmr-canada-banner-150x150.gif
The 2015 Canadian Pharma Market Research Conference is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research in Canada. Nowhere else will you find the industry's best speakers and experts all under one roof!
Market Report
Renal Cell Cancer datamonitor_logo.gif

 

 

Pipeline: Renal Cell Cancer

Introduction
Seven targeted therapies are available for the treatment of RCC but there is still considerable pipeline activity. Currently approved targeted therapies have been unable to produce durable responses in RCC patients and only delay progression. As a consequence, effective treatment options capable of sustaining responses in RCC are still required. 

 
Advertisement
  • Networking Tips & Tricks

    Monitoring news at Farmavita.Net

    You can easily monitor all new articles published  at Farmavita.Net . Click on the RSS button and bookmark the main  RSS feed of Farmavita.Net.  RSS button is located in URL field of your browser and also at the lower right side of every Farmavita.Net page

     
  • Latest Published
 

Featured Partners

 
meddevma14_150x150.gif
bals_150x150_anim.gif 
2015-pmr-canada-banner-150x150.gif   
pharmaccess14b_150x150.gif 
medaff14b_150x150.gif
bals150_150x150.gif 
150x150copd.jpg 
2014-pmr-eur-banner-150x150.gif  
2015-pmr-banner-150x150.gif 
medcommeu15_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 16 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

pc_150x150.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif